CIK 0000920148 · Large accelerated filer
LABCORP HOLDINGS INC.
Sign in to watch- Ticker
- LH
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 992588107
- Phone
- 3362291127
- Business address
- 358 S MAIN ST, BURLINGTON, NC, 27215
- Former names
- LABORATORY CORP OF AMERICA HOLDINGS, NATIONAL HEALTH LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,195,768
- in 4 filings, $1.1M under 10b5-1 plans
Net −$2,195,768. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | Caveney Brian J EVP, Pres of BLS, CMO & CSO | Sale | −2,000 | $372.04 | $744K | 34,562.05 |
| 2026-11-03 | Vaughn Bryan T EVP and President, Diagnostics | Sale 10b5-1 | −306 | $353.70 | $108K | 6,844.91 |
| 2026-11-02 | Oyegunwa Akinbolade EVP, CIO & CTO | Shares withheld for taxes | −118 | $355.59 | $42K | 5,316.25 |
| 2026-11-02 | Vaughn Bryan T EVP and President, Diagnostics | Shares withheld for taxes | −194 | $355.59 | $69K | 7,150.91 |
| 2026-11-01 | Oyegunwa Akinbolade EVP, CIO & CTO | Option exercise | +370 | 5,434.25 | ||
| 2026-11-01 | Oyegunwa Akinbolade EVP, CIO & CTO | Option exercise · Restricted Stock Unit | −370 | 2,570 | ||
| 2026-11-01 | Vaughn Bryan T EVP and President, Diagnostics | Option exercise | +500 | 7,344.91 | ||
| 2026-11-01 | Vaughn Bryan T EVP and President, Diagnostics | Option exercise · Restricted Stock Unit | −500 | 4,704 | ||
| 2026-10-30 | Parham Richelle P Director | Sale | −1,078 | $361.22 | $389K | 2,288 |
| 2026-09-01 | Oyegunwa Akinbolade EVP, CIO & CTO | Grant or award · Restricted Stock Unit | +750 | 2,940 | ||
| 2026-09-01 | Meltzer Jonathan C EVP, COO | Grant or award · Restricted Stock Unit | +900 | 3,594 | ||
| 2026-09-01 | Vaughn Bryan T EVP and President, Diagnostics | Grant or award · Restricted Stock Unit | +1,500 | 5,204 | ||
| 2026-09-01 | Caveney Brian J EVP, Pres of BLS, CMO & CSO | Grant or award · Restricted Stock Unit | +3,000 | 7,170 | ||
| 2026-08-17 | ANDERSON KERRII B Director | Sale 10b5-1 | −3,000 | $318.02 | $954K | 6,563 |
| 2026-08-11 | Schechter Adam H President & CEO | Sale 10b5-1 | −4,669 | $320.37 | $1.5M | 102,565 |
| 2026-08-04 | Summy Amy B. EVP, Chief Marketing Officer | Sale | −924 | $306.74 | $283K | 6,955.5 |
| 2026-08-03 | Wilkinson Peter J SVP, Chief Accounting Officer | Sale | −82 | $309.22 | $25K | 1,770.22 |
| 2026-08-03 | Wilkinson Peter J SVP, Chief Accounting Officer | Option exercise | +1,338 | $209.25 | $280K | 3,108.22 |
| 2026-08-03 | Wilkinson Peter J SVP, Chief Accounting Officer | Sale | −1,338 | $309.23 | $414K | 1,770.22 |
| 2026-08-03 | Wilkinson Peter J SVP, Chief Accounting Officer | Option exercise · Non-qualified Stock Options | −1,338 | 0 |
Page 1 of 14 · 262 trades